CLINICAL_TRIALS
trial_result
· 2012-10-22
Clinical Trial Update: Rituximab in the Treatment of Patients With Bullous Pemphigoid [Phase 1, Phase 2]
Summary
This clinical trial evaluated rituximab for bullous pemphigoid in Phase 1/2, and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Bullous Pemphigoid | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-10-22